Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea.

Autor: Lee, Ji Yeon1 (AUTHOR), Bu, Seon Hee2 (AUTHOR), Song, EunHyang3 (AUTHOR), Cho, Seongcheol4 (AUTHOR), Yu, Sungbong5 (AUTHOR), Kim, Jungok6 (AUTHOR), Kym, Sungmin6 (AUTHOR), Seo, Kwang Won7 (AUTHOR), Kwon, Ki Tae8 (AUTHOR), Kim, Jin Yong9 (AUTHOR), Kim, Sunghyun10 (AUTHOR), Ahn, Keumyoung10 (AUTHOR), Jung, Nahyun10 (AUTHOR), Lee, Yeonmi10 (AUTHOR), Jung, Yoobin10 (AUTHOR), Hwang, Chankyoung10 (AUTHOR), Park, Sang Won11 (AUTHOR) hswon1@snu.ac.kr
Zdroj: Infectious Diseases & Therapy. Oct2023, Vol. 12 Issue 10, p2417-2435. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje